Search: onr:"swepub:oai:gup.ub.gu.se/54018" > Safety and immunoge...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03337naa a2200709 4500 | |
001 | oai:gup.ub.gu.se/54018 | |
003 | SwePub | |
008 | 240528s2007 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/540182 URI |
024 | 7 | a https://doi.org/10.1016/j.vaccine.2006.09.0492 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Anh, Dang Duc4 aut |
245 | 1 0 | a Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. |
264 | 1 | b Elsevier BV,c 2007 |
520 | a Vietnam currently produces an orally administered, bivalent (O1 and O139) killed whole-cell vaccine and is the only country in the world with endemic cholera to use an oral cholera vaccine in public health practice. In order to allow international use, the vaccine had to be reformulated to meet World Health Organization (WHO) requirements. We performed a randomized, placebo controlled, safety and immunogenicity studies of this reformulated vaccine among Vietnamese adults. One hundred and forty-four subjects received the two-dose regimen and 143 had two blood samples obtained for analysis. We found that this reformulated oral killed whole-cell cholera vaccine was safe, well tolerated and highly immunogenic. | |
653 | a Administration | |
653 | a Oral | |
653 | a Adolescent | |
653 | a Adult | |
653 | a Cholera | |
653 | a immunology | |
653 | a microbiology | |
653 | a prevention & control | |
653 | a Cholera Vaccines | |
653 | a administration & dosage | |
653 | a adverse effects | |
653 | a immunology | |
653 | a Double-Blind Method | |
653 | a Female | |
653 | a Humans | |
653 | a Male | |
653 | a Vaccines | |
653 | a Inactivated | |
653 | a administration & dosage | |
653 | a adverse effects | |
653 | a immunology | |
653 | a Vibrio cholerae O1 | |
653 | a immunology | |
653 | a Vibrio cholerae O139 | |
653 | a immunology | |
653 | a Vietnam | |
700 | 1 | a Canh, Do Gia4 aut |
700 | 1 | a Lopez, Anna Lena4 aut |
700 | 1 | a Thiem, Vu Dinh4 aut |
700 | 1 | a Long, Phan Thi4 aut |
700 | 1 | a Son, Nguyen Hong4 aut |
700 | 1 | a Deen, Jacqueline4 aut |
700 | 1 | a von Seidlein, Lorenz4 aut |
700 | 1 | a Carbis, Rodney4 aut |
700 | 1 | a Han, Seung Hyun4 aut |
700 | 1 | a Shin, Seong Hye4 aut |
700 | 1 | a Attridge, Stephen,d 1951u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology4 aut0 (Swepub:gu)xattrs |
700 | 1 | a Holmgren, Jan,d 1944u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology4 aut0 (Swepub:gu)xholja |
700 | 1 | a Clemens, John4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi4 org |
773 | 0 | t Vaccined : Elsevier BVg 25:6, s. 1149-55q 25:6<1149-55x 0264-410X |
856 | 4 8 | u https://gup.ub.gu.se/publication/54018 |
856 | 4 8 | u https://doi.org/10.1016/j.vaccine.2006.09.049 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view